# BRIXADI
> **NDA210136** · New Drug Application · Sponsor: BRAEBURN · Approved 2023-05-23
## Drug
- **FDA Application Number:** NDA210136
- **Application type:** New Drug Application
- **Brand name:** BRIXADI
- **Generic name:** BUPRENORPHINE
- **Active ingredients:** BUPRENORPHINE
- **Dosage form:** SOLUTION, EXTENDED RELEASE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** BRAEBURN
- **Manufacturer:** Braeburn Inc.
- **First approval:** 2023-05-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210136)
---
*MORVS · CC0 1.0*